← Back to headlines
Morgan Stanley Raises Vertex Pharmaceuticals Price Target
Morgan Stanley has increased its price target for Vertex Pharmaceuticals (VRTX) following updates to its biopharma models.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
